REQUEST A DEMO
Total
USD $0.00
Search more companies

Diagnostyka Oncogene Sp. z o.o. (Poland)

Main Activities: All Other Miscellaneous Ambulatory Health Care Services
Full name: Diagnostyka Oncogene Sp. z o.o. Profile Updated: October 18, 2023
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Polish Download a sample report

Oncogene Diagnostics is a molecular genetics company. They specialize in genetic studies for gastroenterology and respiratory tests for Helicobacter pylori infection, and also conduct research on new mutations of the BRCA1 gene. The company has international quality control certificates for cancer-related gene mutations using the NGS technique. They are also involved in developing genetics tests for Southern Poland's population. Their headquarters is located at Ul Mogilska 86, 31-546.

Headquarters
Ul. Mogilska 86/3
Krakow; Malopolskie; Postal Code: 31-546

Contact Details: Purchase the Diagnostyka Oncogene Sp. z o.o. report to view the information.

Website: http://www.oncogene.pl

Basic Information
Total Employees:
Purchase the Diagnostyka Oncogene Sp. z o.o. report to view the information.
Outstanding Shares:
Purchase the Diagnostyka Oncogene Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Diagnostyka Oncogene Sp. z o.o. report to view the information.
Incorporation Date:
September 02, 2010
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Vice President
Ownership Details
Purchase this report to view the information.
66.67%
Purchase this report to view the information.
33.33%
Company Performance
Financial values in the chart are available after Diagnostyka Oncogene Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
95.26%
Total operating revenue
95.25%
Operating profit (EBIT)
139%
EBITDA
129.76%
Net Profit (Loss) for the Period
139.2%
Total assets
77.22%
Total equity
67.89%
Operating Profit Margin (ROS)
5.59%
Net Profit Margin
4.52%
Return on Equity (ROE)
18.81%
Quick Ratio
0.21%
Cash Ratio
0.54%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?